Neomed Management Founded 1997
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 49
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 25
Rounds per year 1.04
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.49
Exits 12
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity
Areas of investment
Biotechnology
Health Care
Hospitality
Industrial
Lifestyle
Summary

Neomed Management appeared to be the VC, which was created in 1997. The fund was located in Europe if to be more exact in Norway. The main department of described VC is located in the Oslo.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Neomed Management, startups are often financed by Andera Partners, Gimv, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Gimv, Legend Capital, BioMedPartners. In the next rounds fund is usually obtained by Andera Partners, OrbiMed, Gimv.

The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sonendo, Creabilis, Wilson Therapeutics.

The overall number of key employees were 3.

The typical startup value when the investment from Neomed Management is 10-50 millions dollars. The top activity for fund was in 2014. The top amount of exits for fund were in 2016. The fund is constantly included in 2-6 investment rounds annually. This Neomed Management works on 7 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 7 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Oxular
Health Care
Medical
Therapeutics
37M01 Mar 2021 United Kingdom, Oxford
JenaValve Technology
Health Care
Medical
Medical Device
Late Stage Venture
50M05 Feb 2020 Germany, Munich
Sonendo
Biotechnology
Health Care
Medical
85M06 Jan 2020 United States, " United States"}
Sequana Medical
Biotechnology
Health Care
Manufacturing
Medical Device
Late Stage Venture
10M16 Oct 2018 Switzerland, Zurich
Sonendo
Biotechnology
Health Care
Medical
Private Equity
50M18 Sep 2017 United States, " United States"}
Avitide
Biotechnology
Health Care
Life Science
Late Stage Venture
12M21 Jun 2017 United States, Lebanon
Axonics Modulation Technologies
Health Diagnostics
Medical
Medical Device
Late Stage Venture
14M02 May 2017 United States, Irvine
Sonendo
Biotechnology
Health Care
Medical
Late Stage Venture
35M13 Dec 2016 United States, " United States"}
4Tech
Manufacturing
Medical Device
Early Stage Venture
29M09 Mar 2016 Ireland, Galway
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Neomed Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: